RT-PCR Molecular Testing for Transplant, Respiratory, and Sexual Health Infections Department of Pathology and Area Laboratory Services (DPALS)
Award Notice Posted
- Solicitation number
- W81K0025CA008
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Awarded
- to Abbott Molecular Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W81K0025CA008 Federal contract award
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Texas 78234, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command awarded a firm fixed price contract (W81K0025CA008) to Abbott Molecular Inc. on June 27, 2025, for RT-PCR molecular testing services related to transplant, respiratory, and sexual health infections. The contract, valued at $1,521,794.33, supports the Department of Pathology and Area Laboratory Services (DPALS) by providing diagnostic testing capabilities for multiple infection categories. As a competitive award with no set-aside restrictions, this contract enables the Army Medical Command to procure specialized molecular testing services to support patient care and infection screening across transplant recipients, respiratory health monitoring, and sexual health diagnostics.
Notice text
Firm Fixed Price, competitve
Awarded contract W81K0025CA008 to ABBOTT MOLECULAR INC. for 1521794.33 on 2025-06-27.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| RT-PCR Molecular Testing for Transplant, Respiratory, and Sexual Health Infections Department of Pathology and Area Laboratory Services (DPALS) | Solicitation | |
| RT-PCR Molecular Testing for Transplant, Respiratory, and Sexual Health Infections Department of Pathology and Area Laboratory Services (DPALS) | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity